Incidence of VTE is high in patients hospitalised with COVID-19. Urgent clinical trials are needed to evaluate the role of anticoagulation in COVID-19. Monitoring of D-dimer and anti-factor Xa levels may be beneficial in guiding management.
No takes yet. Share an insight, caveat, or question.
Stoneham et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: